Topics covered are:

• Unmet needs in cancer prevention
• P4-medicine
• The rationale for utilizing DNA-methylation for cancer risk prediction
• The principle of epigenetic-based risk prediction in surrogate tissue
• Cell type specificity (epithelial cells vs immune cells)
• Responsiveness to risk factors (e.g., progesterone in breast cancer)
• The rationale for cervical smear samples vs. blood or buccal swab
• Embryological considerations
• The WID®-Sola for the risk prediction/stratification of four women’s cancers (cervical, endometrial, ovarian and breast cancer)
• Monitoring preventive measures (e.g., mifepristone for breast cancer)
• WID®-easy and WID®-qCIN (aka “WID®-can”) for the early detection of endometrial cancer and preinvasive cervical cancer
• Monitoring hormone replacement therapy using WID®-REA
• Monitoring preventive measures for healthy aging and longevity using epigenetic signatures
• Personalized pan-cancer prevention

For more information, go to www.eutops.institute